Its proposed mechanism is via regulation of a surrogate cGMP pathway that compensates for the defective nitric oxide-induced cGMP production in DMD, with lower expression of NCALD being protective (Flanigan et al., 2023). The gene discussed is NCALD; the disease is Duchenne muscular dystrophy.